When was Aqueduct Neurosciences founded?

Aqueduct Neurosciences was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is Aqueduct Neurosciences located?

Aqueduct Neurosciences is headquartered in Seattle, United States.

Who is the current CEO of Aqueduct Neurosciences?

Tom Clement of Aqueduct Neurosciences.

How many employees does Aqueduct Neurosciences have?

As of Jul 01, 2024, the latest employee count at Aqueduct Neurosciences is 11 - 50.

Is Aqueduct Neurosciences a funded company?

Aqueduct Neurosciences is a funded company, having raised a total of $8.79M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 30, 2011.

When was the latest funding round of Aqueduct Neurosciences?

Aqueduct Neurosciences' latest funding was a $***** Convertible Debt round on Dec 21, 2016, with participation from 0 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $1.88B in funding in 2026 to date.

Where does Aqueduct Neurosciences rank among its competitors?

Aqueduct Neurosciences ranks 9th amongst 12 active competitors, of which 6 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was CranioSense, which secured $5.5M in Dec, 2025.

Who are the top competitors of Aqueduct Neurosciences?

Aqueduct Neurosciences' top competitors include CereVasc, IRRAS and Longeviti. Among them, CranioSense secured the most recent funding round in December, 2025.

Aqueduct Neurosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Aqueduct Neurosciences is focused on technologies to treat neurological disorders related to the production and regulation of cerebral spinal fluid. Developing an electro-mechanical platform aimed at reducing shunt failure. Also has developed an external CSF drainage system.

Key Metrics

Founded Year

2010

Location

Seattle, United States

Stage

Deadpooled

Total Funding

$8.79M in 4 rounds

Latest Funding Round

Convertible Debt, Dec 21, 2016, $*****

Investors

The Perkins Fund & 3 more

Ranked

9^th among 12 active competitors

Employee Count

11 - 50 as on Jul 01, 2024

Similar Companies

CereVasc & 13 more

View Aqueduct Neurosciences' full profile

Aqueduct Neurosciences has raised a total funding of $8.79M over 4 rounds. Its first funding round was on Aug 30, 2011. Aqueduct Neurosciences has 4 institutional investors.

Here is the list of recent funding rounds of Aqueduct Neurosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 21, 2016	4698484	Convertible Debt	5707410	3726386	1235873	9655397
May 10, 2016	2991037	Series A	7748251	1379930	9714610	Keiretsu Capital
Sep 01, 2011	2853365	Grant (prize money)	6137864	9103939	7103445	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Aqueduct Neurosciences's funding rounds and investors

Aqueduct Neurosciences' employee count trend

Aqueduct Neurosciences has 11 - 50 employees as of Jul 24. Here is Aqueduct Neurosciences's employee count trend over the years:

Employee count trend for Aqueduct Neurosciences

Uncover Aqueduct Neurosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aqueduct Neurosciences include CereVasc, IRRAS and Longeviti. Here is the list of Top 10 competitors of Aqueduct Neurosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CereVasc 2015, Auburndale (United States), Series B	Device for the treatment of patients with communicating hydrocephalus	$114M	Xontogeny, Bain Capital & 1 others	60/100
2nd	IRRAS 2012, Stockholm (Sweden), Acquired	Provider of devices for fluid control and management after surgery	$11.2M	Serendipity Innovations, Invest Stockholm ... & 2 others	56/100
3rd	Longeviti 2014, Hunt Valley (United States), Series B	Developer of implantable neurosurgical devices	$18.2M	TEDCO, GSP Capital	49/100
4th	Tissuemed 1985, Leeds (United Kingdom), Acqui-Hired	Bioadhesive films to prevent body fluid and air leakage during surgery	$12.7M	Saints Capital, Shackleton Ventures & 5 others	49/100
5th	Rhovica 2021, Bern (Switzerland), Seed	Developer of an external ventricular drain to decrease intracranial pressure	$2.92M	M2care, Venture Kick & 2 others	40/100
6th	Aqueduct Critical Care 2013, Bothell (United States), Series A	Novel products to manage Cerebral Spinal Fluid (CSF) pressure	$10.3M	SeaChange Fund, SpringRock Ventures & 5 others	39/100
7th	Spiegelberg 1986, Hamburg (Germany), Acquired	Intracranial pressure(ICP) measuring devices, external ventricular drainage (EVD), shunts and Surgical Instruments.	-	-	31/100
8th	CranioSense 2015, Waltham (United States), Seed	Innovating non-invasive intracranial pressure measurement technology for better brain health	$20K	Techstars, NINDS & 1 others	29/100
9th	Aqueduct Neurosciences 2010, Seattle (United States), Deadpooled	Implantable shunt to treat hydrocephalus	$8.79M	The Perkins Fund, HEDA Ventures & 2 others	28/100
10th	NeuroDx 2008, Bensalem (United States), Funding Raised	Detects CSF flow in shunts using non-invasive thermal dilution	-	Ben Franklin Technology Partners, MentorTech Ventures ... & 3 others	26/100